Araştırma özeti
Aşağıdaki metin kaynak makalenin lisansı doğrulanmış orijinal özetidir. cc by
IntroductionParkinson's Disease (PD) represents the second most prevalent neurodegenerative disorder globally, with traditional assessment methods suffering from limitations including substantial inter-rater variability and inability to capture multifactorial complexity underlying disease progression.MethodsBased on data from 500 Parkinson's disease patients, we integrated 7 standardized clinical phenotypes (excluding UPDRS to prevent data leakage) and 8 environmental exposure factors, compared 10 machine learning algorithms using 5-fold cross-validation, and applied SHAP interpretability analysis for transparent feature importance assessment.ResultsXGBoost with SMOTE sampling achieved clinically meaningful discriminative performance (AUC = 0.781, precision = 0.548, recall = 0.750) appropriate for screening applications. SHAP analysis revealed non-motor symptoms as the primary predictor (SHAP value = 2.76), followed by serum dopamine concentration (2.39) and age (2.16), while environmental factors demonstrated modest but statistically significant contributions.DiscussionThis proof-of-concept study developed an interpretable framework with methodological safeguards against data leakage, demonstrating promising screening potential with realistic performance expectations. However, the cross-sectional, single-center design limits generalizability, requiring external validation and longitudinal studies before clinical deployment.
Bilimsel değerlendirme
Araştırma sorusu
Sorunun kapsamı orijinal çalışma üzerinden değerlendirilir.
Yöntem ve örneklem
Çalışma tasarımı ve örneklem için kaynak makaleyi kontrol edin.
Temel bulgular
Bu kayıt için editoryal olarak onaylanmış bulgu özeti henüz yayımlanmadı.
Sınırlılıklar
Sonuçların genellenebilirliği, yanlılık ve klinik anlamı ayrıca incelenmelidir.
Bibliyografik veriden yöntem, örneklem veya klinik sonuç çıkarımı yapılmaz.